📊 SSII Key Takeaways
Is SS Innovations International, Inc. (SSII) a Good Investment?
SS Innovations is burning $18.5M in annual operating cash while generating only $42.5M in revenue with flat growth, leaving ~2 months of cash runway at current burn rates. Despite improving loss trajectory and reasonable 46% gross margins, the company faces existential liquidity risk unless it dramatically accelerates growth or reduces burn.
Why Buy SS Innovations International, Inc. Stock? SSII Key Strengths
- Gross margin of 46% indicates viable underlying product economics in medical devices
- Operating losses improved 36.7% YoY, showing management action is taking effect
- Current ratio of 1.86x and quick ratio of 1.21x provide near-term liquidity buffer
- No significant long-term debt constraining financial flexibility
SSII Stock Risks: SS Innovations International, Inc. Investment Risks
- Critical cash burn of $18.5M annually against only $3.2M cash on hand (~2 month runway)
- Revenue flat at 0% YoY growth while company remains deeply unprofitable
- Negative operating margin of -19.3% and net margin of -28.5% indicates unsustainable business model
- ROE of -31.7% and ROA of -16.3% destroying shareholder value
- Imminent capital requirement will likely cause significant dilution
Key Metrics to Watch
- Operating cash flow - must turn positive within next 2-3 quarters for survival
- Revenue growth rate - currently flat, needs acceleration to justify ongoing losses
- Cash balance trajectory - monitor monthly burn and runway
- Operating expense ratio - must decline substantially to achieve profitability
SS Innovations International, Inc. (SSII) Financial Metrics & Key Ratios
💡 AI Analyst Insight
SS Innovations International, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
SSII Profit Margin, ROE & Profitability Analysis
SSII vs Healthcare Sector: How SS Innovations International, Inc. Compares
How SS Innovations International, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is SS Innovations International, Inc. Stock Overvalued? SSII Valuation Analysis 2026
Based on fundamental analysis, SS Innovations International, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
SS Innovations International, Inc. Balance Sheet: SSII Debt, Cash & Liquidity
SSII Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: SS Innovations International, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.11 indicates the company is currently unprofitable.
SSII Revenue Growth, EPS Growth & YoY Performance
SSII Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $4.4M | -$3.2M | $-0.02 |
| Q2 2025 | $4.5M | -$256.7K | $0.00 |
| Q1 2025 | $3.6M | -$5.7M | $-0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
SS Innovations International, Inc. Dividends, Buybacks & Capital Allocation
SSII SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for SS Innovations International, Inc. (CIK: 0001676163)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SSII
What is the AI rating for SSII?
SS Innovations International, Inc. (SSII) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SSII's key strengths?
Claude: Gross margin of 46% indicates viable underlying product economics in medical devices. Operating losses improved 36.7% YoY, showing management action is taking effect.
What are the risks of investing in SSII?
Claude: Critical cash burn of $18.5M annually against only $3.2M cash on hand (~2 month runway). Revenue flat at 0% YoY growth while company remains deeply unprofitable.
What is SSII's revenue and growth?
SS Innovations International, Inc. reported revenue of $42.5M.
Does SSII pay dividends?
SS Innovations International, Inc. does not currently pay dividends.
Where can I find SSII SEC filings?
Official SEC filings for SS Innovations International, Inc. (CIK: 0001676163) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SSII's EPS?
SS Innovations International, Inc. has a diluted EPS of $-0.06.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is SSII a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, SS Innovations International, Inc. has a STRONG SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is SSII stock overvalued or undervalued?
Valuation metrics for SSII: ROE of -31.7% (sector avg: 15%), net margin of -28.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy SSII stock in 2026?
Our dual AI analysis gives SS Innovations International, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SSII's free cash flow?
SS Innovations International, Inc.'s operating cash flow is $-18.5M, with capital expenditures of $3.7M. FCF margin is -52.3%.
How does SSII compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -28.5% (avg: 12%), ROE -31.7% (avg: 15%), current ratio 1.86 (avg: 2).